Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-08

Clinical Trial Update: Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates the efficacy and safety of a single low-dose primaquine for clearance of gametocytes in Plasmodium falciparum malaria. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine (primaquine)

Snippet

Sponsor: Muhimbili University of Health and Allied Sciences | Conditions: Plasmodium Falciparum | Phase 4 | Status: COMPLETED